These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6386002)

  • 21. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma.
    Kahaleh MB; Osborn I; Leroy EC
    Ann Intern Med; 1982 May; 96(5):610-3. PubMed ID: 6176160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Controlled clinical trial of the effect of aspirin and aspirin + dipyridamole on the development of diabetic retinopathy. II. Ophthalmologic protocol].
    Diabete Metab; 1982 Dec; 8(4):307-11. PubMed ID: 6761186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized double blind comparison of an aspirin dipyridamole combination versus a placebo in the treatment of necrobiosis lipoidica.
    Statham B; Finlay AY; Marks R
    Acta Derm Venereol; 1981; 61(3):270-1. PubMed ID: 6167117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitor.
    Strobl-Jäger E; Kaliman J; Sinzinger H
    Prostaglandins Leukot Med; 1984 Aug; 15(2):241-50. PubMed ID: 6436832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
    Fuster V; Chesebro JH
    Circulation; 1986 Feb; 73(2):227-32. PubMed ID: 3510762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of acetyl salicylic acid and dipyridamole on thromboembolic complications in splenectomized patients with myelofibrosis.
    Hansen MS; Christensen BE; Jønsson V
    Scand J Haematol; 1979 Sep; 23(3):177-81. PubMed ID: 504965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin-dipyridamole prophylaxis of sickle cell disease pain crises.
    Chaplin H; Alkjaersig N; Fletcher AP; Michael JM; Joist JH
    Thromb Haemost; 1980 Jul; 43(3):218-21. PubMed ID: 7006142
    [No Abstract]   [Full Text] [Related]  

  • 30. A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease.
    Davis JW; Hartman CR; Shelton L; Ruttinger HA
    Am J Cardiol; 1989 Jun; 63(20):1450-4. PubMed ID: 2524959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Necrobiosis lipoidica diabeticorum: platelet survival and response to platelet inhibitors.
    Quimby SR; Muller SA; Schroeter AL; Fuster V; Kazmier FJ
    Cutis; 1989 Mar; 43(3):213-6. PubMed ID: 2707053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of combined aspirin and dipyridamole therapy on thrombus formation in an arterial thrombogenic lesion in the dog.
    Deen HG; Sundt TM
    Stroke; 1982; 13(2):179-84. PubMed ID: 7064188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prevention of stroke: does dipyridamole add to aspirin?
    Lowenthal A; Buyse M
    Acta Neurol Belg; 1994; 94(1):24-34. PubMed ID: 8140884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of aortocoronary vein-graft attrition with low-dose aspirin and triflusal, both associated with dipyridamole: a randomized, double-blind, placebo-controlled trial.
    Guiteras P; Altimiras J; Arís A; Augé JM; Bassons T; Bonal J; Caralps JM; Castellarnau C; Crexells C; Masotti M
    Eur Heart J; 1989 Feb; 10(2):159-67. PubMed ID: 2647494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of aspirin plus dipyridamole in reducing left ventricular thrombus formation in anterior wall acute myocardial infarction.
    Johannessen KA; Stratton JR; Taulow E; Osterud B; von der Lippe G
    Am J Cardiol; 1989 Jan; 63(1):101-2. PubMed ID: 2642365
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of adjunctive dipyridamole to DAPT on platelet function profiles in stented patients with high platelet reactivity. The result of the ACCEL-DIP Study.
    Park Y; Jeong YH; Tantry US; Ahn JH; Kim KH; Koh JS; Park JR; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA
    Thromb Haemost; 2014 Dec; 112(6):1198-208. PubMed ID: 25182660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of aspirin, clopidogrel and dipyridamole administered singly and in combination on platelet and leucocyte function in normal volunteers and patients with prior ischaemic stroke.
    Zhao L; Fletcher S; Weaver C; Leonardi-Bee J; May J; Fox S; Willmot M; Heptinstal S; Bath P
    Thromb Haemost; 2005 Mar; 93(3):527-34. PubMed ID: 15735805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet drugs in thromboembolism.
    Hirsh J
    Postgrad Med; 1979 Sep; 66(3):119-23, 126-7. PubMed ID: 382146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
    Khajehdehi P; Roozbeh J; Mostafavi H
    Scand J Urol Nephrol; 2002; 36(2):145-8. PubMed ID: 12028688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.